$UnitedHealth (UNH) Rebounds +2.85%: TD Cowen Upgrade Fuels Recovery, $347-$392 Breakout Range in...

๐Ÿ“Š Market Recap

As of November 21, 2026 (US Eastern Time), 'UNH' closed at $339.89, up +2.85% (+$9.40) from the previous close of $330.48. The stock is trading approximately 26.4% below its 52-week high of $461.62, while sitting about 32.8% above its 52-week low of $255.97. The immediate rebound follows days of heavy selling pressure driven by CMS audit expansion risks and potential antitrust breakup concerns.

๐Ÿš€ Key Drivers

  • TD Cowen Upgrade: The firm upgraded 'UNH' from Hold to Buy and raised its target price from $402 to $455, naming it a top 2027 investment idea, which significantly boosted investor sentiment.
  • Regulatory Overhang: CMS plans to strengthen Medicare Advantage audits and fraud recovery enforcement remain a key headwind, compressing valuations across the managed care sector.
  • Litigation & Breakup Risk: Ongoing claims-processing lawsuits from large employers and uncertainty around a potential company split continue to weigh on long-term stability expectations.

๐ŸŽฏ Price Outlook

Short-Term Upside/Downside Probability

Direction Probability Price Range Change
Upside 58% 347 - 370 +2% ~ +9%
Downside 42% 325 - 330 -2% ~ -4%

Medium-Term Upside/Downside Probability

Direction Probability Price Range Change
Upside 55% 390 - 420 +15% ~ +24%
Downside 45% 290 - 310 -9% ~ -15%

Key Price Ranges

Type Price
Short-Term Resistance 347 / 370
Short-Term Support 330 / 325
Strong Support Zone 299

(The above forecast results are generated by AI and are for reference only. They do not constitute any form of investment advice, trading guidance, or return commitment.)

The following is a technical, valuation, and short-term catalyst analysis based on market data. Data and information are sourced from public records; opinions are for reference only and do not constitute direct trading advice.

1. Technical Analysis ๐Ÿ“ˆ

Volume: Trading volume reached 12.69 million shares with a volume ratio of 1.19, indicating moderately active participation. Turnover ratio was 1.41%, suggesting a slight pick-up in interest following the recent bounce.

MACD: DIF (-10.56) remains deeply below DEA (-2.04), with the MACD histogram at -17.04. The negative momentum is still dominant, but the sharp RSI recovery suggests the bearish trend may be losing steam.

RSI: The 6-day RSI recovered to 22.36 from an oversold low of 11.79, while the 12-day RSI improved to 28.05. Both are still in the weak zone but are climbing, indicating a potential short-term reversal signal after heavy overselling.

2. Key Price Levels ๐ŸŽฏ

Primary Support: $299.18 (previous swing low from November 20). A break below this level would signal a continuation of the downtrend toward $290.

Strong Resistance: $392.87 (recent rebound pivot from November 20). This level must be reclaimed to shift the medium-term bias back to bullish.

Immediate Pivot: $341.00 (pre-market price of the latest session). Holding above this level would support a push toward $347.45, the session high.

3. Valuation Perspective ๐Ÿ’ฐ

Current TTM P/E ratio is 19.43, which is close to the historical forward PE average of 18.68. The latest forward PE of 16.04 sits below the -1 standard deviation level of 16.22, indicating the stock is trading at a notable discount relative to its own history. The price-to-sales ratio stands at 0.68, reflecting depressed expectations due to regulatory and litigation concerns.

4. Analyst Targets ๐ŸŽฏ

A total of 28 institutions have provided target prices, with an average target of $469.77, ranging from a low of $313 to a high of $531. Rating distribution: 7 Strong Buy, 17 Buy, and 4 Hold. The consensus target implies substantial upside from current levels, though recent downgrades by Wells Fargo and Bernstein highlight growing caution.

5. Weekly Outlook ๐Ÿ”ฎ

Over the next week, 'UNH' is expected to trade within a range of $325 to $370. A sustained break above $347 could open a path toward $390, while a drop below $330 would likely trigger a retest of the $299 primary support. Volatility may remain elevated as the market digests regulatory headlines.

Key events to watch in the next 1-2 weeks:

  • Further updates on CMS Medicare Advantage audit proposals and fraud recovery enforcement scope.
  • Any new litigation filings or settlements related to claims-processing disputes.
  • Sector-wide sentiment shifts for managed care peers, including Humana, Molina, and Elevance Health.

Risk Disclaimer โš ๏ธ

This content is for informational purposes only and does not constitute investment advice. Stock market investing carries risks, and past performance does not guarantee future results. 'UNH' faces heightened regulatory and legal uncertainties that could cause significant price swings independent of fundamental performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet